Fulvio Guglielmi

Erratum to: Expression of human apolipoprotein A-I in Nicotiana tabacum

R. Piccoli, A. Arciello, E. Filippone, 2013, Biotechnology Letters.

Insights into the fate of the N-terminal amyloidogenic polypeptide of ApoA-I in cultured target cells

D. Monti, R. Piccoli, A. Arciello, 2011, Journal of cellular and molecular medicine.

Enzymatically active fibrils generated by the self-assembly of the ApoA-I fibrillogenic domain functionalized with a catalytic moiety.

D. Monti, R. Piccoli, A. Arciello, 2009, Biomaterials.

Effects of the known pathogenic mutations on the aggregation pathway of the amyloidogenic peptide of apolipoprotein A-I.

C. Dobson, Paul Robustelli, S. Doglia, 2011, Journal of molecular biology.

Effects of a lipid environment on the fibrillogenic pathway of the N-terminal polypeptide of human apolipoprotein A-I, responsible for in vivo amyloid fibril formation

D. Monti, R. Piccoli, M. Monti, 2010, European Biophysics Journal.

Recombinant amyloidogenic domain of ApoA-I: analysis of its fibrillogenic potential.

C. Dobson, R. Piccoli, A. Arciello, 2006, Biochemical and Biophysical Research Communications - BBRC.